Rapid development of glomerular injury and renal failure in mice lacking p53R2

被引:32
作者
Powell, DR
Desai, U
Sparks, MJ
Hansen, G
Gay, J
Schrick, J
Shi, ZZ
Hicks, J
Vogel, P
机构
[1] Lexicon Genet Inc, Dept Endocrinol, The Woodlands, TX 77381 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
关键词
nephrotic syndrome; podocyte; gene trap; knockout; glomerulopathy;
D O I
10.1007/s00467-004-1696-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The Rrm2b gene encodes p53R2, a catalytic subunit of ribonucleotide reductase that is required for DNA repair. Embryonic stem (ES) cells containing a retroviral insertion in the Rrm2b locus were used to generate mutant mice. Analysis of kidney RNA from Rrm2b ( -/-) mice showed that the retroviral insertion disrupted expression of Rrm2b transcripts. Rrm2b ( -/-) pups were represented at the expected Mendelian ratios at 10 - 12 days of age and grew normally past weaning. Mice failed to thrive after 6 weeks of age and began to die by 8 weeks of age. Phenotyping revealed that Rrm2b (-/-) mice died from a severe glomerular lesion that led to nephrotic syndrome and chronic renal failure. In kidneys of Rrm2b (-/-) mice, podocytes were enlarged and there was evidence of foot process effacement by 6 weeks of age. By 8 weeks of age, progressive podocyte hypertrophy and loss of foot processes was accompanied by hypertrophy of glomerular capillary endothelial cells that was extensive enough to restrict capillary blood flow. Collapsing glomerulopathy with avascular glomeruli was widespread in mice surviving beyond 9 weeks of age. Additional abnormalities in other organ systems were minor or consistent with secondary effects of renal failure. These findings suggest that lack of p53R2, the protein encoded by Rrm2b, has early and relatively selective detrimental effects on the kidney glomerulus that lead to rapid death from progressive renal failure.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 30 条
[1]   Full-speed mammalian genetics:: in vivo target validation in the drug discovery process [J].
Abuin, A ;
Holt, KH ;
Platt, KA ;
Sands, AT ;
Zambrowicz, BP .
TRENDS IN BIOTECHNOLOGY, 2002, 20 (01) :36-42
[2]  
BELTRANDELRIO H, IN PRESS MODEL ORGAN
[3]  
Benigni A, 1996, SEMIN NEPHROL, V16, P151
[4]   NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome [J].
Boute, N ;
Gribouval, O ;
Roselli, S ;
Benessy, F ;
Lee, H ;
Fuchshuber, A ;
Dahan, K ;
Gubler, MC ;
Niaudet, P ;
Antignac, C .
NATURE GENETICS, 2000, 24 (04) :349-354
[5]  
COUNCIL NR, 1996, GUIDE CARE USE LAB A
[6]   Pathologic classification of focal segmental glomerulosclerosis: A working proposal [J].
D'Agati, VD ;
Fogo, AB ;
Bruijn, JA ;
Jennette, JC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (02) :368-382
[7]   Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN [J].
Donoviel, DB ;
Freed, DD ;
Vogel, H ;
Potter, DG ;
Hawkins, E ;
Barrish, JP ;
Mathur, BN ;
Turner, CA ;
Geske, R ;
Montgomery, CA ;
Starbuck, M ;
Brandt, M ;
Gupta, A ;
Ramirez-Solis, R ;
Zambrowicz, BP ;
Powell, DR .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (14) :4829-4836
[8]   The role of VEGF-A in glomerular development and function [J].
Eremina, V ;
Quaggin, SE .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (01) :9-15
[9]   Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases [J].
Eremina, V ;
Sood, M ;
Haigh, J ;
Nagy, A ;
Lajoie, G ;
Ferrara, N ;
Gerber, HP ;
Kikkawa, Y ;
Miner, JH ;
Quaggin, SE .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :707-716
[10]   Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy [J].
Ghiggeri, GM ;
Carraro, M ;
Vincenti, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1036-1040